News

G1/21 hearing at the EPO

May 2021

Event date: 28th May 2021

Follow this page for the updates from G1/21 hearing at the EPO on 28th May 2021. HGF Partners Dr Chris Moore and Douglas Drysdale will be reporting all the key moments throughout the day. We will provide a round up after the hearing both in English and German.

Happy World IP Day!

This year’s theme is ‘IP and the SDGs: Building our common future with innovation and creativity’. At HGF we are committed to supporting our clients in sustainable technologies and routinely …

Read article

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

We will all recognise as consumers an instance of when we used the colour of a product or its packaging to identify a specific brand that we wanted to buy …

Read article

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article

See all updates

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Office.	+44 (0)1224 258 510
Email.	[email protected]

Office.	+44 (0)161 247 4900
Email.	[email protected]

Office.	+31(0) 20 809 5628
Email.	[email protected]

Office.	+41 (0)61 225 4480
Email.	[email protected]

Contact Us

Aberdeen

Alderley Park

Amsterdam

Basel

Belfast

Bern

Birmingham

Dresden

Dublin

Edinburgh

Glasgow

Heidelberg

Leeds

London

Manchester

Munich

Newcastle

Nottingham

Oxford

Rennes

Salzburg

Sheffield

The Hague

Westport

York

G1/21 hearing at the EPO

Event date: 28th May 2021

Summary of the case

Overview of the case

Social media updates

Latest updates

Happy World IP Day!

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

Medical 3D Technologies: From Scanning to Printing

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

IP Ingredients Blog, Parts 11-20

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials